Neola Medical

0.88 SEK

Less than 1K followers

NEOLA

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Dividend

Investor consensus

+0.46 %

+3.77 %

-16.98 %

-23.14 %

-62.23 %

-61.40 %

-52.04 %

-77.40 %

-84.14 %

Neola Medical operates in the medical technology sector. The company focuses on neonatal care, where it develops medical equipment. Examples of products that the company provides to the healthcare sector include technical monitoring and follow-up of lung capacity in premature infants. In addition to the main product, ancillary products and disposables are offered. The largest operations are found in the Nordic market. Neola Medical was founded in 2016 and is headquartered in Sweden.

Market cap

68.6M SEK

Turnover

-

Revenue

-

EBIT %

-

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue K

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

19.5

2026

Interim report Q1'26

28.5

2026

General meeting '26

20.8

2026

Interim report Q2'26

All

Press releases

3rd party

ShowingAll content types

Press release2/13/2026, 11:59 AM

Redeye: Neola Medical (Q4 Review): Eyes on upcoming clinical data

Regulatory press release2/12/2026, 6:00 AM

Neola Medical Q4 Report 2025 – Advancing IP Protection as a Core Strategic Asset across Key Markets

Press release2/5/2026, 7:00 AM

Neola Medical invites to presentation of the Q4-report 2025

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release12/17/2025, 10:40 AM

Neola Medical’s CEO shares recent company highlights in winter 2025 investor letter

Regulatory press release12/9/2025, 6:00 AM

Neola Medical expands leadership team with appointment of Director Disposable Product Development

Press release12/2/2025, 6:00 AM

Neola Medical granted U.S. patent for disposable probes, strengthening future revenue model in target market

Press release11/13/2025, 6:00 AM

Neola Medical granted Patent in China for reducing optical noise in lung monitoring measurements

Press release11/7/2025, 7:37 AM

Redeye: Neola Medical (Q3 Review) - Revised timeline

Regulatory press release11/4/2025, 5:57 PM

Neola Medical Q3 Report 2025 – Progressing toward completion of Swedish clinical pilot study and strengthening leadership team

Regulatory press release11/4/2025, 5:53 PM

Revised Timeline Announced as Clinical Pilot Study Indicates Robust Safety and Need for Optimization of Neola®

Press release10/16/2025, 6:00 AM

Neola Medical Strengthens Global IP Portfolio with New Patents Granted in both the U.S. and China for Medical Device Neola®

Press release10/1/2025, 5:00 AM

Neola Medical’s CEO highlights recent progress in autumn 2025 investor letter

Regulatory press release9/25/2025, 5:20 AM

Neola Medical strengthens leadership team with appointment of Clinical Director

Press release9/10/2025, 5:00 AM

Neola Medical granted European patent enabling lung monitoring beyond preterm born babies

Press release8/26/2025, 12:26 PM

Redeye: Neola Medical Q2 - Potential share price trigger incoming

Regulatory press release8/25/2025, 5:55 AM

Neola Medical Q2 Report 2025 – First U.S. Clinical Study Site Agreement Signed, Key Step in Regulatory Path to Market Authorization

Press release8/18/2025, 5:00 AM

Neola Medical invites to presentation of the Q2-report 2025

Press release6/16/2025, 9:00 AM

Neola Medical’s CEO shares clinical progress and recent milestones in summer 2025 investor letter

Press release6/10/2025, 5:00 AM

Neola Medical Signs Agreement with Leading U.S. Hospital for Pivotal Clinical Study on Preterm Born Babies Following IRB Approval

Press release5/22/2025, 10:59 AM

Redeye: Neola Medical Q1 - Clinical progress on track

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.